5/10/2019: Senate Finance hearing on MACRA in its third year…Status of the FY 2020 appropriations process…Recently-passed House bills on drug pricing, pre-existing conditions.
5/3/2019: The latest plans from CMS to reform primary care…CBO weighs in on single-payer…House subcommittee passes FY2020 LHHS appropriations bill.
4/12/2019: Overview of CMS’ final rule to promote telehealth in MA…Ned Sharpless, the FDA’s new acting commissioner…E&C Oversight Subcommittee’s hearing on high insulin prices.
4/5/2019: President Trump’s decision to move forward on ACA replacement after 2020 elections…Federal judge says association health plans rule violates the ACA and ERISA…Azar’s third congressional appearance on HHS budget.
3/29/2019: House Democrats’ new bill to increase access to insurance coverage…The DOJ’s decision to affirm the district court ruling in Texas v. Azar…Highlights from Brookings discussion on solutions to surprise medical bills.
3/15/2019: President Trump’s FY 2020 budget request…RFI from CMS on selling insurance plans across state lines…New efforts to address concerns over hospital mergers and acquisitions.
3/8/2019: Republican Senators’ push to examine drug rebates…The latest Medicare-for-All proposal…A busy week of hearings on drug prices.
3/1/2019: Stakeholder feedback on proposed NBPP for 2020…New RFI on grandfathered group health plans…Recap of Azar’s State of the Department address.
2/22/2019: CMMI’s new model on emergency medical services…Overview of recently-introduced Medicare buy-in legislation…New projections on 2017-2028 health care spending.
2/15/2019: The newly proposed CMS rule to advance interoperability…Azar’s remarks on drug prices, value-based care…Summary of bipartisan bill to boost support for Medicare-funded GME.
2/8/2019: Reactions to the proposed changes to drug rebates…Health care highlights from the State of the Union…Azar’s remarks on drug prices at AcademyHealth conference.
2/1/2019: New efforts to address surprise medical bills…Senate Finance Committee’s first hearing this year on drug prices…Gottlieb’s remarks on using real world evidence in FDA clinical trials.
1/25/2019: Overview of new Part D, updated MA VBID models…The proposed Notice of Benefit and Payment Parameters for 2020…Health priorities of top E&C Democrats.
1/18/2019: Democrats’ concerns of shutdown’s effect on premium tax credits and marketplace enrollment…AG nominee William Barr’s health care positions…The Trump Administration’s new guidance on Medicaid.
1/11/2019: Status update on the partial government shutdown…overview of the new rules package for the 11th Congress…summary of PAHPA, Medicaid extenders.
12/20/2018: What the district court ruling in Texas means for the ACA…Recommendations for implementing Medicaid DSH cuts…The farm bill’s health care provisions.
12/14/2018: Overview of five Medicaid bills passed in the House on December 11…How the IMPROVE Act would penalize companies that misclassify drugs…The bipartisan maternity health bill headed to the White House.
12/7/2018: The Administration’s new Section 1332 waiver concepts for states…New recommendations on increasing competition and choice in health care…The collapse of bipartisan budget reform efforts.
11/30/2018: An overview of CMS’ proposed rule on Medicare Advantage and Part D drug pricing…Azar’s remarks on hospitals potentially using Medicaid dollars to pay for housing…An update on the CREATES Act.
11/16/2018: Where things stand on the makeup of the 116th Congress…An update on efforts to reform the budget and appropriations process…Key health care agenda items for Congressional Democrats next year.
10/19/2018: A recap of major 2018 health care legislation.
10/4/2018: The prospects for Tax Reform 2.0…Seema Verma’s comments on Medicare, Medicaid at the Atlantic Festival…Overview of stakeholder comments on proposed OPPS, ASC payment system changes.
9/27/2018: The conference agreement on opioids legislation…Summary of the Supporting Grandparents Raising Grandchildren Act…Health care reactions to proposed changes to public charge rule.
9/20/2018: A look at CMS’s proposed rule to reduce regulatory burdens on providers…An update on legislation to eliminate the gag clause….HELP Committee’s hearing on how improving transparency can address high health care costs.
9/13/2018: Status report on LHHS appropriations for FY 2019…An overview of Tax Reform 2.0…Summaries of four Medicare bills passed in the House.
8/2/2018: Highlights from CMS’ proposed rule on OPPS and ASC payment rates…Senate HELP Committee’s hearing on reducing administrative spending in health care…The return of risk adjustment payments.
7/26/2018: An overview of health care bills recently passed in the House…FDA’s new working group on drug importation…Details of drug manufacturers’ announcements on price reductions and price freezes.
7/19/2018: CMS’ latest cuts to the Navigator Program…Overview of HSA and insurance bills approved by House Ways and Means Committee…A brief look at proposed Physician Fee Schedule and Quality Payment Program changes for Contract Year 2019.
7/12/2018: A look at Brett Kavanaugh, Trump’s pick for SCOTUS…CMS’ proposed home health payment changes for 2019…Key points from the Administration’s plan to reorganize the federal government.
6/28/2018: The latest plan by conservative organizations to repeal the ACA…The health care priorities of House Republicans’ FY19 budget resolution.
6/22/2018: How the ACA is factoring into the midterms…The DOL’s final rule on association health plans…House GOP proposals to expand health savings accounts.
6/18/2018: A look into DOJ’s decision to defend the ACA’s consumer protections…Alex Azar’s testimony before the Senate HELP Committee on the President’s drug pricing plan…Cuts to CHIP and CMMI in House-passed rescissions bill.
6/6/2018: A preview of the Congressional healthcare agenda for this summer…An update on projected premium increases and Medicaid expansion in the states…Key takeaways from the annual Medicare Trustees report.
5/18/2018: Status of efforts in the House and Senate to combat the opioid crisis…An overview of the Administration’s blueprint to lower drug prices…Update on states’ efforts to seek waivers for individual market and Medicaid programs.
5/10/2018: White House to unveil plan to reduce drug prices…HHS delay of 340B price ceiling rule…Significant increases in CY19 insurance premiums in early rate filings.
4/19/2018: Highlights from CBO’s Budget and Economic Outlook for 2018-2028…An executive order to explore expanding work requirements and direct reevaluation of safety net programs…New Jersey’s new law to reinstate the individual mandate penalty and fund a reinsurance pool.
4/12/2018: An overview of the final 2019 MA rule to increase plan payments by 3.4%…More state flexibility in plan year 2019 ACA benefits and payment final rule…The White House’s consideration of rescission process to roll back omnibus spending.
3/29/2018: Health provisions in the $1.3 trillion omnibus spending package…The White House plan to combat opioid addiction…FDA’s advance notice of proposed rulemaking regarding implementation of a product standard to lower nicotine in cigarettes to non-addictive levels.
3/15/2018: Highlights from speeches by HHS Secretary Azar, FDA Commissioner Gottlieb and CMS Administrator Verma.
3/8/2018: Individual insurance market stabilization measures and the omnibus…Congressional and DOJ action on opioids…Center for American Progress proposal called “Medicare Extra.”
2/28/2018: A blueprint for improving the nation’s health care system from a bipartisan group of governors… The House Energy and Commerce Health Subcommittee hearing on bipartisan legislative proposals to address the opioid epidemic… The President’s Council of Economic Advisors annual report on the administration’s domestic and international economic policy priorities.
2/22/2018: The House Energy and Commerce Subcommittee on Oversight and Investigations on the effects of consolidation within the health care industry…Our take on Idaho’s proposal to allow the sale of non-ACA compliant individual market plans and state action to expand their Medicaid programs.
2/14/2018: Trump administration’s Fiscal Year 2019 Department of Health and Human Services budget proposal…Insurance market stabilization efforts…A report on 2018 ACA enrollment.
2/7/2018: Highlights from Part II of the draft Medicare Advantage and Part D Call Letter Rate Notice… Congressional and FDA efforts to address the opioid crisis…The recent Amazon/Berkshire/JPM Healthcare partnership announcement.
2/1/2018: Health insurance market stabilization measures…340B Drug Pricing Program legislation…State Medicaid activity.
1/18/2018: CMS guidance on state Medicaid work requirement demonstrations…The House Energy and Commerce Committee Republicans’ release a report on the 340B Drug Pricing Program and 2018 FDA priorities.
1/10/2018: The Department of Labor regulations on association health plans…Hospitals’ lawsuit on 340B…Advance Notice of calendar year 2019 methodological changes for the Medicare Advantage Risk Adjustment Model.
12/20/2017: The Trump administration’s Fall 2017 Unified Agenda and federal agencies’ regulatory priorities for FY18…December’s Medicaid and CHIP Payment and Access Commission meeting…Newly-passed Republican tax legislation.
12/13/2017: Outstanding health care items on the congressional to-do list…MedPAC’s consideration of proposed changes to post-acute care payment systems…Preview of FDA’s public meeting in January on ways to better ensure the safe use of opioids.
12/6/2017: Senate HELP Committee hearing on Alex Azar’s nomination to serve as HHS secretary… CMS’ cancellation of the Episode Payment Models, Cardiac Rehabilitation Incentive Payment Model, plus changes to the Comprehensive Care for Joint Replacement Model…A look at end-of-year health care legislation.
11/30/2017: Health care provisions in the tax reform legislation…Overview of 2019 Medicare Advantage and Prescription Drug Benefit proposed rule…Preliminary 2018 ACA enrollment data.
11/7/2017: A look at final CMS rules on CY18 Hospital Outpatient and Ambulatory Surgical Center, Home Health, and Physician Fee Schedule.
10/31/2017: Proposed CMS rule on federally-facilitated and state-based exchange plan benefit and payment parameters for CY19…Senate Finance Committee’s draft proposal on Medicare Extenders…CMS’ End-Stage Renal Disease final CY18 payment rule.
10/25/2017: Congress’ and the Administration’s approach to the national opioid crisis…The White House’s health care priorities…Section 1332 waiver updates.
10/11/2017: A look at the CHRONIC Act…Overview of ACA market stabilization efforts…Recent efforts by states to impose transparency requirements on pharmaceutical pricing.
10/5/2017: The status of Medicare extenders…Proposed 340B reimbursement reductions…The search for a new HHS secretary.
9/27/2017: Recap of activity around Graham-Cassidy…RFI on changes to the Center for Medicare and Medicaid Innovation…A list of upcoming regulations from HHS.
9/20/2017: Update on Graham-Cassidy…A look at the President’s Opioid Commission report…Pending CHIP legislation.
9/13/2017: Senate HELP Committee’s bipartisan hearings on ACA stabilization…Overview of CR/debt limit extension…The status of Graham-Cassidy-Heller’s ACA replace legislation.
8/9/2017: Highlights of the recently-passed FDA User Fee legislation…Quick guide on pending legislative priorities for September…Appropriations tracker and chart on increases in the statutory debt ceiling since 1990.
5/17/2017: Recently-approved FDA user fee legislation by the Senate HELP Committee plus the drug pricing debate…The challenges of extending the CHIP in a bipartisan way…Insurer announcements that are driving the current debate over the ACA’s insurance exchanges.
5/4/2017: The FY2017 omnibus appropriations agreement so far…The CREATES Act and generic drug competition…The President’s tax reform proposal and its effects on health-related tax items.
4/6/2017: Roundup of ACA news stories…A look at Democratic drug pricing legislation…The impact of proposed budget cuts to the National Institutes of Health.
3/24/2017: Vote on the American Health Care Act suspended…Senate Finance Committee Ranking Member Ron Wyden’s legislation on pharmacy benefit managers…HHS Secretary Tom Price and CMS Administrator Seema Verma letter to governors on the Medicaid program.
3/16/2017: The President’s FY 2019 Budget Request, with a focus on HHS’ budget priorities.
3/15/2017: CBO score of the American Health Care Act…President Trump to nominate Steven Gottlieb for FDA Commissioner…State flexibility under Section 1132 waivers.
3/10/2017: Review of committee markups of the American Health Care Act…House Education and the Workforce Committee’s markup of health legislation.
3/1/2017: Budget outlook for Fiscal Years 2017 and 2018…Highlights of recently-introduced legislation to allow drug importation…The leaked House Republican draft of legislation to repeal and replace the ACA.
2/22/2017: Summary of the House Republican policy proposal on repealing and replacing the Affordable Care Act…CMS’ proposed rule on ACA market stabilization…CMS Actuary’s National Health Expenditure Report.
2/10/2017: House Energy and Commerce Committee’s legislation on generic drug pricing…Senate Finance Committee’s contentious nomination hearing on Rep. Tom Price for HHS Secretary…Recently-introduced legislation to stop the Independent Payment Advisory Board process.
1/26/2017: House Ways and Means Oversight Subcommittee’s hearing on the ACA’s individual mandate…President Trump’s recent Executive Order on the ACA…Republican plans for repealing and replacing the ACA.
1/20/2017: The recent focus on drug pricing in Congress…Senate Finance Committee Republicans’ roundtable with Republican Governors on Medicaid reform…The latest on efforts to repeal and replace the ACA in Congress.
1/11/2017: Divisions among Senate Republicans over timeline and strategy for ACA repeal and replacement…Summary of House Ways and Means Health Subcommittee’s draft legislation on value-based purchasing for post-acute care…Overview of changes in committee leadership in the 115th Congress.
1/5/2017: Senate Aging Committee’s bipartisan report on generic drug price increases…Highlights of legislation on Congress’ ability to block regulations…Overview of the confirmation process for President-elect Trump’s cabinet nominees.